Advertisement

Nutritional Management of Calcium Stones

  • Donna E. GjesvoldEmail author
Chapter
Part of the Nutrition and Health book series (NH)

Abstract

Calcium-containing stones are the most common type of kidney stones. The historic record documents attempts at dietary intervention for millennia. The prevalence of stone disease is increasing, and diet is often a contributing factor. Nutrition therapy for risk modification is promising, but there are many research gaps due to the complexities of conducting high-quality clinical trials. The American Urological Association (AUA) published guideline statements based on graded evidence and expert opinion in 2014 for medical management of kidney stones, and these statements provide a framework for nutrition therapy. Medical and nutrition therapies provide separate yet synergistic benefit, and a coordinated approach best supports the patient for effective treatment of calcium stone disease and is valuable for preventing recurrence.

Keywords

Citrate Hypercalciuria Hyperoxaluria Hypocitraturia Microbiome Nephrolithiasis Oxalate Potential renal acid load Supersaturation Calcium phosphate stones Uric acid 

Abbreviations

AHRQ

Agency for Healthcare Research and Quality

AUA

American Urological Association

CT

Computed tomography

DASH

Dietary Approaches to Stop Hypertension

NHANES

National Health and Nutrition Examination Survey

PRAL

Potential renal acid load

PTH

Parathyroid hormone

RCT

Randomized controlled trial

References

  1. 1.
    Modlin M. A history of urinary stone. S Afr Med J. 1980;58(652–655):114.Google Scholar
  2. 2.
    Mandel NS, Mandel GS. Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition. J Urol. 1989;142(6):1516–21.PubMedCrossRefGoogle Scholar
  3. 3.
    Geller MJ, Cohen SL. Kidney and urinary tract disease in ancient Babylonia, with translations of the cuneiform sources. Kidney Int. 1995;47(6):1811–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, Monga M, Penniston KL, Preminger GM, Turk TM, White JR. Medical management of kidney stones: AUA guideline. J Urol. 2014;192(2):316–24.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Scales CD, Smith AC, Hanley JM, Saigal CS. Urologic diseases in America project. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160–5.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Uribarri J, Oh MS, Carroll HJ. The first kidney stone. Ann Intern Med. 1989;111(12):1006–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Saigal CS, Joyce G, Timilsina AR, Urologic Diseases in America Project. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int. 2005;68(4):1808–14.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR, Brasure M, Kane RL, Monga M. Recurrent nephrolithiasis in adults: comparative effectiveness of preventive medical strategies.Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 July Report No.: 12-EHC049-EF.Google Scholar
  9. 9.
    Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293(4):455–62.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Borghi L, Meschi T, Guerra A, Briganti A, Schianchi T, Allegri F, Novarini A. Essential arterial hypertension and stone disease. Kidney Int. 1999;55(6):2397–406.PubMedCrossRefGoogle Scholar
  11. 11.
    Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68(3):1230–5.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155(3):839–43.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Soda and other beverages and the risk of kidney stones. Clin J Am Soc Nephrol. 2013;8(8):1389–95.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Sorensen MD, Kahn AJ, Reiner AP, Tseng TY, Shikany JM, Wallace RB, Chi T, Wactawski-Wende J, Jackson RD, O’Sullivan MJ, Sadetsky N. Impact of nutritional factors on incident kidney stone formation: a report from the WHI OS. J Urol. 2012;187(5):1645–50.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Wallace RB, Wactawski-Wende J, O’Sullivan MJ, Larson JC, Cochrane B, Gass M, Masaki K. Urinary tract stone occurrence in the Women’s Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements. Am J Clin Nutr. 2011;94(1):270–7.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354(7):669–83.PubMedCrossRefGoogle Scholar
  17. 17.
    Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346(2):77–84.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Noori N, Honarkar E, Goldfarb DS, Kalantar-Zadeh K, Taheri M, Shakhssalim N, Parvin M, Basiri A. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets. Am J Kidney Dis. 2014;63(3):456–63.PubMedCrossRefGoogle Scholar
  19. 19.
    Taylor EN, Fung TT, Curhan GC. DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol. 2009;20(10):2253–9.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Rebholz CM, Crews DC, Grams ME, Steffen LM, Levey AS, Miller ER, Appel LJ, Coresh J. DASH (Dietary Approaches to Stop Hypertension) diet and risk of subsequent kidney disease. Am J Kidney Dis. 2016;68(6):853–61.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Taylor EN, Curhan GC. Determinants of 24-hour urinary oxalate excretion. Clin J Am Soc Nephrol. 2008;3(5):1453–60.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Massey LK. Food oxalate: factors affecting measurement, biological variation, and bioavailability. J Am Diet Assoc. 2007;107(7):1191–4.PubMedCrossRefGoogle Scholar
  23. 23.
    Attalla K, De S, Monga M. Oxalate content of food: a tangled web. Urology. 2014;84(3):555–60.PubMedCrossRefGoogle Scholar
  24. 24.
    Taylor EN, Curhan GC. Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol. 2007;18(7):2198–204.PubMedCrossRefGoogle Scholar
  25. 25.
    Hylander E, Jarnum S, Nielsen K. Calcium treatment of enteric hyperoxaluria after jejunoileal bypass for morbid obesity. Scand J Gastroenterol. 1980;15(3):349–52.PubMedCrossRefGoogle Scholar
  26. 26.
    Worcester EM. Stones from bowel disease. Endocrinol Metab Clin N Am. 2002;31(4):979–99.CrossRefGoogle Scholar
  27. 27.
    Baxmann AC, De OG Mendonca C, Heilberg IP. Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients. Kidney Int. 2003;63(3):1066–71.PubMedCrossRefGoogle Scholar
  28. 28.
    Tang M, Larson-Meyer DE, Liebman M. Effect of cinnamon and turmeric on urinary oxalate excretion, plasma lipids, and plasma glucose in healthy subjects. Am J Clin Nutr. 2008;87(5):1262–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology. 2001;57(1):26–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Zuckerman JM, Assimos DG. Hypocitraturia: pathophysiology and medical management. Rev Urol. 2009;11(3):134–44.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Ryall RL. Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation. World J Urol. 1997;15(3):155–64.PubMedCrossRefGoogle Scholar
  32. 32.
    Adeva MM, Souto G. Diet-induced metabolic acidosis. Clin Nutr. 2011;30(4):416–21.PubMedCrossRefGoogle Scholar
  33. 33.
    Trinchieri A, Lizzano R, Marchesotti F, Zanetti G. Effect of potential renal acid load of foods on urinary citrate excretion in calcium renal stone formers. Urol Res. 2006;34(1):1–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Remer T, Manz F. Potential renal acid load of foods and its influence on urine pH. J Am Diet Assoc. 1995;95(7):791–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Meschi T, Maggiore U, Fiaccadori E, Schianchi T, Bosi S, Adorni G, Ridolo E, Guerra A, Allegri F, Novarini A, Borghi L. The effect of fruits and vegetables on urinary stone risk factors. Kidney Int. 2004;66(6):2402–10.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Sakhaee K, Alpern R, Poindexter J, Pak CY. Citraturic response to oral citric acid load. J Urol. 1992;147(4):975–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Kang DE, Sur RL, Haleblian GE, Fitzsimons NJ, Borawski KM, Preminger GM. Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis. J Urol. 2007;177(4):1358–62.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Aras B, Kalfazade N, Tuğcu V, Kemahlı E, Özbay B, Polat H, Taşçı Aİ. Can lemon juice be an alternative to potassium citrate in the treatment of urinary calcium stones in patients with hypocitraturia? A prospective randomized study. Urol Res. 2008;36(6):313–7.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Bobulescu IA, Moe OW. Renal transport of uric acid: evolving concepts and uncertainties. Adv Chronic Kidney Dis. 2012;19(6):358–71.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Worcester E, Coe F. Nephrolithiasis. Prim Care Clin Office Pract. 2008;35:369–91.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Hennepin Healthcare Kidney CenterMinneapolisUSA

Personalised recommendations